$NEPH SEC Filings

Filed On	Filing
14 Oct 2026	Proxy statement: annual meeting on October 12, 2026 CEO pay $627K, up 53% · say-on-pay vote
13 Oct 2026	8-K: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11; Other Events Nephros, Inc. 380 Lackawanna Place South Orange NJ 07079 Call: 201 343 5202
16 Sep 2026	SCHEDULE 13D/A
16 Sep 2026	SCHEDULE 13G
16 Sep 2026	Form 4: Wexford Capital Lp, 10% owner and 3 others Disposed of 3,377,821 shares (Other Transaction)
16 Sep 2026	Form 4: Amron Arthur H, Director and 1 other Acquired 43,295 shares (Other Transaction)
20 Aug 2026	Form 4: Wexford Capital Lp, 10% owner and 3 others Received 812 shares by exercise or conversion ($2.92K)
14 Aug 2026	Form 4: Amron Arthur H, Director Received 2,418 shares as a grant or award
10 Aug 2026	10-Q
06 Aug 2026	8-K: Results of Operations and Financial Condition
15 Jun 2026	8-K: Regulation FD Disclosure
12 Jun 2026	Form 4: Amron Arthur H, Director Received 3,574 shares as a grant or award
07 May 2026	8-K: Results of Operations and Financial Condition
07 May 2026	10-Q
30 Apr 2026	10-K/A
27 Mar 2026	8-K: Regulation FD Disclosure
25 Mar 2026	Form 4: Banks Robert R. Jr., President and CEO Received 120,000 shares by exercise or conversion ($173K)
25 Mar 2026	Form 4: Krandel Judy, Chief Financial Officer Received 68,861 shares by exercise or conversion ($118K)
18 Mar 2026	Form 4: Amron Arthur H, Director Received 3,610 shares as a grant or award
18 Mar 2026	Form 4: Krandel Judy, Chief Financial Officer Granted 4,000 Stock Option (right to buy)

Comments